In prostate cancer cells, Ilvesaro et al reported that stimulation of TLR9 with its agonistic CpG-containing ligands increased invasion in human prostate cancer cells by upregulation of MMP13 [15]. This evidence concerns the gene MMP13 and prostate carcinoma.